Previous Article | Next Article 
Infect Immun. 1990 August; 58(8): 2564-2568
Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome.
P R Meylan,
D D Richman and
R S Kornbluth
Department of Medicine, University of California, School of Medicine, San Diego.
ABSTRACT
Strains of the Mycobacterium avium complex (MAC) yield opaque and transparent colonial variants when cultivated in vitro. The transparent variants are more virulent than the opaque for animals, but little is known about the respective roles of these colonial variants in humans. To assess which variant infects humans, various blood fractions from eight patients with MAC bacteremia were plated directly onto 7H10 agar. In cell fractionation studies, all the M. avium complex CFU were associated with leukocytes and none were found free in plasma. All colonies on the primary culture plate exhibited the transparent phenotype. However, during subculture in 7H9 broth or on Lowenstein-Jensen agar, opaque variants appeared in seven of eight strains. Isogenic pairs of transparent and opaque variants were prepared and used to infect in vitro human monocyte-derived macrophages from healthy seronegative individuals. Transparent variants invariably grew inside macrophages, but only one of seven opaque variants did so. These observations indicate that the bacteremia of M. avium complex in acquired immunodeficiency syndrome patients consists exclusively of the transparent variants, perhaps because these variants are able to multiply inside macrophages. In contrast, opaque variants appear after in vitro subculture and are controlled by human macrophages, consistent with their reduced virulence in animals.
Infect Immun. 1990 August; 58(8): 2564-2568
This article has been cited by other articles:
-
Wittkowski, M., Mittelstadt, J., Brandau, S., Reiling, N., Lindner, B., Torrelles, J., Brennan, P. J., Holst, O.
(2007). Capsular Arabinomannans from Mycobacterium avium with Morphotype-specific Structural Differences but Identical Biological Activity. J. Biol. Chem.
282: 19103-19112
[Abstract]
[Full Text]
-
da Silva, T. R. M., de Freitas, J. R., Silva, Q. C., Figueira, C. P., Roxo, E., Leao, S. C., de Freitas, L. A. R., Veras, P. S. T.
(2002). Virulent Mycobacterium fortuitum Restricts NO Production by a Gamma Interferon-Activated J774 Cell Line and Phagosome-Lysosome Fusion. Infect. Immun.
70: 5628-5634
[Abstract]
[Full Text]
-
Blumenthal, A., Ehlers, S., Ernst, M., Flad, H.-D., Reiling, N.
(2002). Control of Mycobacterial Replication in Human Macrophages: Roles of Extracellular Signal-Regulated Kinases 1 and 2 and p38 Mitogen-Activated Protein Kinase Pathways. Infect. Immun.
70: 4961-4967
[Abstract]
[Full Text]
-
Tse, H. M., Josephy, S. I., Chan, E. D., Fouts, D., Cooper, A. M.
(2002). Activation of the Mitogen-Activated Protein Kinase Signaling Pathway Is Instrumental in Determining the Ability of Mycobacterium avium to Grow in Murine Macrophages. J. Immunol.
168: 825-833
[Abstract]
[Full Text]
-
Hayashi, T., Rao, S. P., Takabayashi, K., Van Uden, J. H., Kornbluth, R. S., Baird, S. M., Taylor, M. W., Carson, D. A., Catanzaro, A., Raz, E.
(2001). Enhancement of Innate Immunity against Mycobacterium avium Infection by Immunostimulatory DNA Is Mediated by Indoleamine 2,3-Dioxygenase. Infect. Immun.
69: 6156-6164
[Abstract]
[Full Text]
-
Fattorini, L., Baldassarri, L., Li, Y.-J., Ammendolia, M. G., Fan, Y., Recchia, S., Iona, E., Orefici, G.
(2000). Virulence and drug susceptibility of Mycobacterium celatum. Microbiology
146: 2733-2742
[Abstract]
[Full Text]
-
Fratazzi, C., Manjunath, N., Arbeit, R. D., Carini, C., Gerken, T. A., Ardman, B., Remold-O'Donnell, E., Remold, H. G.
(2000). A Macrophage Invasion Mechanism for Mycobacteria Implicating the Extracellular Domain of CD43. JEM
192: 183-192
[Abstract]
[Full Text]
-
Birkness, K. A., Swords, W. E., Huang, P.-H., White, E. H., Dezzutti, C. S., Lal, R. B., Quinn, F. D.
(1999). Observed Differences in Virulence-Associated Phenotypes between a Human Clinical Isolate and a Veterinary Isolate of Mycobacterium avium. Infect. Immun.
67: 4895-4901
[Abstract]
[Full Text]
-
Hayashi, T., Rao, S. P., Meylan, P. R., Kornbluth, R. S., Catanzaro, A.
(1999). Role of CD40 Ligand in Mycobacterium avium Infection. Infect. Immun.
67: 3558-3565
[Abstract]
[Full Text]
Copyright © 1990 by the American Society for Microbiology. All rights reserved.